Market Research Report
Precision Medicine Market Report 2022-2032: Forecasts by Product Type (Diagnostics, Therapeutics), by Application, by End-user, Regional & Leading National Market Analysis, Leading Companies, and COVID-19 Recovery Scenarios
|Precision Medicine Market Report 2022-2032: Forecasts by Product Type (Diagnostics, Therapeutics), by Application, by End-user, Regional & Leading National Market Analysis, Leading Companies, and COVID-19 Recovery Scenarios|
Published: July 5, 2022
Visiongain Reports Ltd.
Content info: 441 Pages
Delivery time: 1-2 business days
Precision Medicine Market Report 2022-2032
Forecasts by Product Type (Diagnostics (Genetic Tests, Biomarker-based Tests, Others), Therapeutics), by Application (Oncology, CNS, Immunology, Respiratory, Others), by End-user (Hospitals, Diagnostic Centres, Research & Academic Institutes, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios.
The Precision Medicine Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Some of the major forces propelling the global precision medicine market include increasing global burden of cancer, rising demand for targeted therapy, and growing precedence of precision medicine. According to Cancer Research UK, an estimated 23.6 million new cases of cancer will be reported in 2030 worldwide which can be attributed to factors such as population growth and rise in geriatric population. Based on these statistics, basic and translational cancer research continues to be of utmost importance.
A better understanding of the genetic characteristics or biomarkers of an individual can promote the practice or administering the right drug, at the right time, at the right dose, for the right person. Implementation of patient-selection diagnostic set-up in the earlier phases of drug development has been the core objective of pharmacological, pharmaceutical and biopharmaceutical firms for which significant efforts are being put so that targeted therapies are delivered to the right candidate which further supplements the growth of the precision medicine market. Furthermore, the increase in scope of application of precision medicine is expected to propel market growth. Precision medicine have numerous application areas, which includes oncology, central nervous system (CNS), immunology, respiratory and other diseases. Several studies are exploring the possibilities of developing diagnostic tests and therapeutics for other cancer indications, such as prostate cancer, ovarian cancer, and leukaemia. New entrants have identified this opportunity to venture into the market by developing tests for rare indications, such as ovarian cancer.
Precision medicine may be well-established in pharma industry, however overwhelming cost hinder its reach to payers, patients, and physicians. This high initial cost puts these tests and therapies out of reach of a large portion of end users particularly those in developing countries despite of its benefits and assured returns on investment.
The lack of data interoperability is another key barrier in achieving precision medicines to its full potential. Without international data standards on genomic data, it is not possible to integrate data on genetic markers into patient records that would help researchers to understand why particular set of population is particularly susceptible to a decease. Also, diagnostics has always been perceived as a small step in a healthcare program, and insufficient funding in this space particularly in emerging economies further impedes the market growth.
This report tells you TODAY how the Precision Medicine market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V" , "L" , "W" and "U" are discussed in this report.
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
The report also includes profiles and for some of the leading companies in the Precision Medicine Market, 2022 to 2032, with a focus on this segment of these companies' operations.
Overall world revenue for Precision Medicine Market, 2022 to 2032 in terms of value the market will surpass US$63,333 million in 2021, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
In summary, our 440+ page report provides you with the following knowledge:
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Precision Medicine Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.
Visiongain is a trading partner with the US Federal Government.